What factors should be considered in a risk assessment of recombinant research with pathogenic viruses?
NIH Guidelines Section II-A-3. Comprehensive Risk Assessment states, In deciding on the appropriate containment for an experiment, the initial risk assessment from Appendix B, Classification of Human Etiologic Agents on the Basis of Hazard, should be followed by a thorough consideration of the agent itself and how it is to be manipulated.
Related Questions
- What biosafety levels of containment are currently being used for recombinant research with 1918 influenza viruses, highly pathogenic avian influenza viruses, and SARS-CoV?
- What factors should be considered in a risk assessment of recombinant research with pathogenic viruses?
- What does a risk assessment involve and what are the safety factors?
